Active Filters

  • (-) Organizational Unit = Urban Water Management SWW
  • (-) Eawag Authors = Escher, Beate I.
Search Results 1 - 11 of 11
  • CSV Spreadsheet
  • Excel Spreadsheet
  • RSS Feed
Select Page
Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater
Le Corre, K. S., Ort, C., Kateley, D., Allen, B., Escher, B. I., & Keller, J. (2012). Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater. Environment International, 45(1), 99-111. https://doi.org/10.1016/j.envint.2012.03.008
Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater
Escher, B. I., Baumgartner, R., Koller, M., Treyer, K., Lienert, J., & McArdell, C. S. (2011). Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Research, 45(1), 75-92. https://doi.org/10.1016/j.watres.2010.08.019
Mixture toxicity of the antiviral drug Tamiflu<SUP>®</SUP> (oseltamivir ethylester) and its active metabolite oseltamivir acid
Escher, B. I., Bramaz, N., Lienert, J., Neuwoehner, J., & Straub, J. O. (2010). Mixture toxicity of the antiviral drug Tamiflu® (oseltamivir ethylester) and its active metabolite oseltamivir acid. Aquatic Toxicology, 96(3), 194-202. https://doi.org/10.1016/j.aquatox.2009.10.020
Predicting the ecotoxicological effects of transformation products
Escher, B. I., Baumgartner, R., Lienert, J., & Fenner, K. (2009). Predicting the ecotoxicological effects of transformation products. In A. B. A. Boxall (Ed.), The handbook of environmental chemistry: Vol. 2. Transformation products of synthetic chemicals in the environment (pp. 205-244). https://doi.org/10.1007/698_2_015
Can NoMix help to prevent environmental problems caused by medicines?
Escher, B., & Lienert, J. (2007). Can NoMix help to prevent environmental problems caused by medicines? Eawag News [engl. ed.], 63, 23-25.
Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine
Lienert, J., Bürki, T., & Escher, B. I. (2007). Reducing micropollutants with source control: substance flow analysis of 212 pharmaceuticals in faeces and urine. Water Science and Technology, 56(5), 87-96. https://doi.org/10.2166/wst.2007.560
Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes
Lienert, J., Güdel, K., & Escher, B. I. (2007). Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environmental Science and Technology, 41(12), 4471-4478. https://doi.org/10.1021/es0627693
Elimination of β-blockers in sewage treatment plants
Maurer, M., Escher, B. I., Richle, P., Schaffner, C., & Alder, A. C. (2007). Elimination of β-blockers in sewage treatment plants. Water Research, 41(7), 1614-1622. https://doi.org/10.1016/j.watres.2007.01.004
Pilot experiments with electrodialysis and ozonation for the production of a fertiliser from urine
Pronk, W., Zuleeg, S., Lienert, J., Escher, B., Koller, M., Berner, A., … Boller, M. (2007). Pilot experiments with electrodialysis and ozonation for the production of a fertiliser from urine. Water Science and Technology, 56(5), 219-227. https://doi.org/10.2166/wst.2007.575
Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach
Escher, B. I., Bramaz, N., Richter, M., & Lienert, J. (2006). Comparative ecotoxicological hazard assessment of beta-blockers and their human metabolites using a mode-of-action-based test battery and a QSAR approach. Environmental Science and Technology, 40(23), 7402-7408. https://doi.org/10.1021/es052572v
Monitoring the removal efficiency of pharmaceuticals and hormones in different treatment processes of source-separated urine with bioassays
Escher, B. I., Pronk, W., Suter, M. J. F., & Maurer, M. (2006). Monitoring the removal efficiency of pharmaceuticals and hormones in different treatment processes of source-separated urine with bioassays. Environmental Science and Technology, 40(16), 5095-5101. https://doi.org/10.1021/es060598w